Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Feb;7(2):297-303.
doi: 10.2215/CJN.07970811. Epub 2011 Dec 1.

A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study

Affiliations
Randomized Controlled Trial

A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study

Rory F McQuillan et al. Clin J Am Soc Nephrol. 2012 Feb.

Abstract

Background and objectives: Infectious complications remain a significant cause of peritoneal dialysis (PD) technique failure. Topical ointments seem to reduce peritonitis; however, concerns over resistance have led to a quest for alternative agents. This study examined the effectiveness of applying topical Polysporin Triple ointment (P(3)) against mupirocin in a multi-centered, double-blind, randomized controlled trial.

Design, setting, participants, & measurements: PD patients routinely applied either P(3) or mupirocin ointment to their exit site. Patients were followed for 18 months or until death or catheter removal. The primary study outcome was a composite endpoint of exit-site infection (ESI), tunnel infection, or peritonitis.

Results: Seventy-five of 201 randomized patients experienced a primary outcome event (51 peritonitis episodes, 24 ESIs). No difference was seen in the time to first event for P(3) (13.2 months; 95% confidence interval, 11.9-14.5) and mupirocin (14.0 months; 95% confidence interval, 12.7-15.4) (P=0.41). Twice as many patients reported redness at the exit site in the P(3) group (14 versus 6, P=0.10). Over the complete study period, a higher rate per year of fungal ESIs was seen in patients using P(3) (0.07 versus 0.01; P=0.02) with a corresponding increase in fungal peritonitis (0.04 versus 0.00, respectively; P<0.05).

Conclusions: This study shows that P(3) is not superior to mupirocin in the prophylaxis of PD-related infections. Colonization of the exit site with fungal organisms is of concern and warrants further study. As such, the use of P(3) over mupirocin is not advocated in the prophylaxis of PD-related infections.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flow diagram showing patient recruitment and follow-up. HD, hemodialysis.
Figure 2.
Figure 2.
Kaplan–Meier graph showing time to primary end point (catheter-related infection). Solid line indicates mupirocin; dashed line, P3 ointment. PD, peritoneal dialysis; Mup, mupirocin; P3, Polysporin Triple.

Similar articles

Cited by

References

    1. Mujais S: Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 103: S55–S62, 2006 - PubMed
    1. Johnson DW, Dent H, Hawley CM, McDonald SP, Rosman JB, Brown FG, Bannister KM, Wiggins KJ: Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am J Kidney Dis 53: 290–297, 2009 - PubMed
    1. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye WC, Salzer W, Schaefer F, Struijk DG: Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 30: 393–423, 2010 - PubMed
    1. Al-Hilali NA, Ninan VT, Al-Humoud HA, Nampoory MR, Johny KV: Mupirocin once weekly reduces the incidence of catheter exit-site infection in peritoneal dialysis patients. Perit Dial Int 25: 91–92, 2005 - PubMed
    1. Aykut S, Caner C, Ozkan G, Ali C, Tugba A, Zeynep G, Taner C: Mupirocin application at the exit site in peritoneal dialysis patients: Five years of experience. Ren Fail 32: 356–361, 2010 - PubMed

Publication types

MeSH terms